A Contract Development and Manufacturing Organization handles drug development and production for other pharma or biotech companies. The work spans process development, scale-up, GMP manufacturing, fill-finish, packaging, and analytical testing.

Which European countries have the most CDMO capacity?

Switzerland and Germany lead by depth and quality (Basel, Heidelberg, Mainz). Poland adds large-scale manufacturing capacity, Lithuania has a growing biologics CDMO presence anchored in Vilnius, and the Nordics carry strong fill-finish and aseptic operators in Denmark and Sweden.

How are these CDMO companies verified?

Every profile is hand-reviewed against an audit framework: leadership identity confirmed by primary source, physical site address sourced from official disclosures, regulatory matrix (GMP / ISO-13485 / GLP / FDA-Inspected) backed by certification documents, and a registry note explaining the company's current operating context.

Can I compare two CDMO providers side by side?

Yes — use the Compare button on any company card to add it to a comparison set (up to 3 companies), then open the /compare page for a side-by-side view of leadership, certifications, and operating scale.

Category and country

CDMO companies in Estonia

2 cdmo profiles in Estonia. Every profile is hand-reviewed with leadership, certifications, and public sources.

All Estonia biotech CDMO across Europe

Profiles2

Verified2

With certifications2

Cities1

Category view

Where does cdmo cluster in Estonia?

Tartu (2) Most visible profiles: Icosagen Group and TBD Pharmatech.

Category view

Which standards are already visible?

GMP (2) Latest review: 14 March 2026. Review cycle: March 2026.

Full list

CDMO profiles in Estonia

2 profiles match the active filter.

Tartu antibody-discovery and recombinant-protein platform now reinforced by a 1,600 m2 cGMP production facility and a broad partner network.

Lead: Mart UstavFounder and CEO
Scale: Clinical CDMO and cGMP protein manufacturing

Tartu API CDMO providing process chemistry, analytical development, scale-up, and GMP-oriented manufacturing support for small-molecule pharmaceutical programs.

Lead: Dr. Andrus TasaChairman of the Management Board
Scale: Clinical CDMO

Related brief

Read deeper on this category

Market brief

European CDMO Capacity 2026: Biologics, Fill-Finish, Small Molecule

Where to look for biologics, fill-finish, small-molecule, and specialised CDMO capacity across Europe in 2026 — 33 CDMOs in the directory across 9 countries, organised by what they actually do and where they sit.

Open brief

FAQ

Frequently asked questions on this category

What is a CDMO?: A Contract Development and Manufacturing Organization handles drug development and production for other pharma or biotech companies. The work spans process development, scale-up, GMP manufacturing, fill-finish, packaging, and analytical testing.
Which European countries have the most CDMO capacity?: Switzerland and Germany lead by depth and quality (Basel, Heidelberg, Mainz). Poland adds large-scale manufacturing capacity, Lithuania has a growing biologics CDMO presence anchored in Vilnius, and the Nordics carry strong fill-finish and aseptic operators in Denmark and Sweden.
How are these CDMO companies verified?: Every profile is hand-reviewed against an audit framework: leadership identity confirmed by primary source, physical site address sourced from official disclosures, regulatory matrix (GMP / ISO-13485 / GLP / FDA-Inspected) backed by certification documents, and a registry note explaining the company's current operating context.
Can I compare two CDMO providers side by side?: Yes — use the Compare button on any company card to add it to a comparison set (up to 3 companies), then open the /compare page for a side-by-side view of leadership, certifications, and operating scale.

Next step

Compare companies or open the wider market.

Use the compare tool to view two or three companies side by side, or open the country hub for the full market view.

Open compare Open Tartu Suggest a company